PriceTargets.com logo

Aveanna Healthcare - AVAH Stock Price Target and Predictions

  • Consensus Rating: Moderate Buy
  • Consensus Price Target: $11.06
  • Forecasted Upside: 32.80%
  • Number of Analysts: 11
  • Breakdown:
  • 0 Sell Ratings
  • 5 Hold Ratings
  • 5 Buy Ratings
  • 1 Strong Buy Ratings
$8.33 As of 02/2/2026 05:00 PM ET
▼ -0.07 (-0.83%)

This chart shows the closing price for AVAH by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Aveanna Healthcare Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for AVAH and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for AVAH

Analyst Price Target is $11.06
▲ +32.80% Upside Potential
This price target is based on 11 analysts offering 12 month price targets for Aveanna Healthcare in the last 3 months. The average price target is $11.06, with a high forecast of $13.00 and a low forecast of $10.00. The average price target represents a 32.80% upside from the last price of $8.33.

This chart shows the closing price for AVAH for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Moderate Buy

The current consensus among 11 polled investment analysts is to moderate buy stock in Aveanna Healthcare. This rating changed within the last month from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 3 sell ratings
Ratings as of
8/11/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 2 sell ratings
Ratings as of
11/9/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 2 hold ratings
  • 1 sell ratings
Ratings as of
2/7/2025
  • 0 strong buy ratings
  • 1 buy ratings
  • 2 hold ratings
  • 1 sell ratings
Ratings as of
5/8/2025
  • 0 strong buy ratings
  • 2 buy ratings
  • 3 hold ratings
  • 1 sell ratings
Ratings as of
8/6/2025
  • 0 strong buy ratings
  • 3 buy ratings
  • 6 hold ratings
  • 0 sell ratings
Ratings as of
11/4/2025
  • 0 strong buy ratings
  • 5 buy ratings
  • 6 hold ratings
  • 0 sell ratings
Ratings as of
1/3/2026
  • 1 strong buy ratings
  • 5 buy ratings
  • 5 hold ratings
  • 0 sell ratings
Ratings as of
2/2/2026

Latest Recommendations

  • 1 strong buy ratings
  • 5 buy ratings
  • 5 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
1/20/2026Zacks ResearchUpgradeHold ➝ Strong-Buy
1/16/2026BarclaysBoost TargetOverweight ➝ Overweight$9.00 ➝ $11.00
1/15/2026UBS GroupBoost TargetNeutral ➝ Neutral$9.50 ➝ $10.00
1/15/2026Royal Bank Of CanadaBoost TargetSector Perform ➝ Sector Perform$10.00 ➝ $11.00
12/29/2025Weiss RatingsReiterated RatingHold (C+) ➝ Hold (C+)
12/8/2025William BlairInitiated CoverageOutperform
12/5/2025Raymond James FinancialReiterated RatingOutperform ➝ Outperform$13.00
11/13/2025BMO Capital MarketsInitiated CoverageOutperform$11.00
11/7/2025UBS GroupBoost TargetNeutral ➝ Neutral$9.00 ➝ $9.50
11/7/2025Truist FinancialBoost TargetHold ➝ Hold$9.50 ➝ $10.00
10/28/2025Jefferies Financial GroupBoost TargetBuy ➝ Buy$11.00 ➝ $12.50
10/24/2025Royal Bank Of CanadaBoost TargetSector Perform ➝ Sector Perform$8.00 ➝ $10.00
10/20/2025Zacks ResearchDowngradeStrong-Buy ➝ Hold
10/13/2025UBS GroupBoost TargetNeutral ➝ Neutral$8.00 ➝ $9.00
10/8/2025Weiss RatingsReiterated RatingHold (C) ➝ Hold (C)
9/27/2025Weiss RatingsReiterated RatingHold (C) ➝ Hold (C)
9/18/2025JPMorgan Chase & Co.UpgradeUnderweight ➝ Neutral$6.00 ➝ $10.00
8/19/2025BarclaysUpgradeEqual Weight ➝ Overweight$5.50 ➝ $9.50
8/19/2025UBS GroupUpgradeSell ➝ Neutral$6.75 ➝ $8.00
8/12/2025UBS GroupBoost TargetSell ➝ Sell$5.00 ➝ $6.75
8/11/2025Raymond James FinancialUpgradeMarket Perform ➝ Outperform$9.00
7/21/2025Jefferies Financial GroupUpgradeHold ➝ Buy$6.25 ➝ $6.00
7/16/2025Truist FinancialLower TargetHold ➝ Hold$6.00 ➝ $5.00
7/2/2025BarclaysInitiated CoverageEqual Weight$5.50
5/9/2025UBS GroupBoost TargetSell ➝ Sell$4.50 ➝ $5.00
4/11/2025Truist FinancialLower TargetHold ➝ Hold$6.00 ➝ $5.50
3/14/2025UBS GroupBoost TargetSell ➝ Sell$3.20 ➝ $4.50
1/6/2025Truist FinancialLower TargetHold ➝ Hold$6.00 ➝ $5.25
8/9/2024Royal Bank Of CanadaBoost TargetSector Perform ➝ Sector Perform$3.00 ➝ $5.00
8/9/2024Deutsche Bank AktiengesellschaftBoost TargetBuy ➝ Buy$3.00 ➝ $5.00
8/9/2024UBS GroupBoost TargetSell ➝ Sell$1.70 ➝ $2.80
3/18/2024Deutsche Bank AktiengesellschaftBoost TargetBuy ➝ Buy$2.00 ➝ $3.00
12/13/2023JPMorgan Chase & Co.DowngradeNeutral ➝ Underweight
11/30/2023UBS GroupInitiated CoverageSell$1.50
8/11/2023Credit Suisse GroupReiterated RatingUnderperform ➝ Underperform$1.00
7/13/2023Truist FinancialBoost TargetHold$1.40 ➝ $1.70
5/12/2023Raymond James FinancialDowngradeStrong-Buy ➝ Market Perform
3/17/2023Raymond James FinancialLower Target$4.00 ➝ $3.00
3/17/2023Truist FinancialBoost TargetHold$1.00 ➝ $1.40
3/17/2023Deutsche Bank AktiengesellschaftLower Target$3.00 ➝ $1.70
1/27/2023Credit Suisse GroupDowngradeNeutral ➝ Underperform$2.00 ➝ $1.00
11/21/2022Royal Bank Of CanadaDowngradeOutperform ➝ Sector Perform$7.00 ➝ $3.00
11/17/2022Credit Suisse GroupDowngradeOutperform ➝ Neutral$5.50 ➝ $2.00
11/16/2022Truist FinancialLower Target$1.25
11/11/2022StephensLower TargetEqual Weight$2.25 ➝ $1.50
9/6/2022StephensLower Target$2.50
8/19/2022BarclaysLower TargetOverweight$7.00 ➝ $5.00
8/15/2022Raymond James FinancialLower TargetStrong-Buy$8.00 ➝ $6.00
7/22/2022StephensLower Target$2.75
7/22/2022Credit Suisse GroupLower Target$5.50
7/22/2022Jefferies Financial GroupDowngradeBuy ➝ Hold$2.50
7/5/2022Truist FinancialDowngradeBuy ➝ Hold$2.50
6/21/2022Bank of AmericaDowngradeNeutral ➝ Underperform$3.00 ➝ $2.00
6/21/2022StephensDowngradeOverweight ➝ Equal Weight$5.50 ➝ $3.50
3/31/2022Royal Bank Of CanadaLower TargetOutperform$16.00 ➝ $9.00
3/31/2022Raymond James FinancialLower TargetStrong-Buy$12.00 ➝ $8.00
3/30/2022Truist FinancialLower TargetBuy$10.00 ➝ $5.00
3/30/2022Credit Suisse GroupLower TargetOutperform$12.00 ➝ $9.50
3/30/2022Deutsche Bank AktiengesellschaftLower TargetBuy$12.50 ➝ $6.00
3/30/2022StephensLower TargetOverweight$11.50 ➝ $7.00
3/30/2022BarclaysLower TargetOverweight$16.00 ➝ $7.00
3/29/2022Bank of AmericaDowngradeBuy ➝ Neutral$10.00 ➝ $5.50
11/23/2021Raymond James FinancialLower TargetStrong-Buy$15.00 ➝ $12.00
11/18/2021BMO Capital MarketsLower TargetOutperform$17.00 ➝ $12.00
11/17/2021Deutsche Bank AktiengesellschaftLower TargetBuy$13.50 ➝ $12.50
10/13/2021Truist FinancialLower TargetBuy$15.00 ➝ $10.00
5/24/2021Truist FinancialInitiated CoverageBuy$15.00
5/24/2021BMO Capital MarketsInitiated CoverageOutperform$17.00
5/24/2021Jefferies Financial GroupInitiated CoverageBuy$15.00
5/24/2021JPMorgan Chase & Co.Initiated CoverageNeutral$14.00
5/24/2021Royal Bank Of CanadaInitiated CoverageOutperform$16.00
5/24/2021Credit Suisse GroupInitiated CoverageOutperform$16.00
5/24/2021Deutsche Bank AktiengesellschaftInitiated CoverageBuy$13.50
5/24/2021Raymond James FinancialInitiated CoverageStrong-Buy$15.00
5/24/2021BarclaysInitiated CoverageOverweight$20.00
(Data available from 2/2/2021 forward)

News Sentiment Rating

0.79 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 13 very positive mentions
  • 7 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/7/2025
  • 3 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
8/6/2025
  • 10 very positive mentions
  • 18 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
9/5/2025
  • 7 very positive mentions
  • 10 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
10/5/2025
  • 15 very positive mentions
  • 21 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
Mentions as of
11/4/2025
  • 13 very positive mentions
  • 7 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
Mentions as of
12/4/2025
  • 22 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
1/3/2026
  • 9 very positive mentions
  • 11 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
2/2/2026

Current Sentiment

  • 9 very positive mentions
  • 11 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

Aveanna Healthcare logo
Aveanna Healthcare Holdings Inc., a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities. The company operates through three segments: Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). The PDS segment offers PDN services, which include in-home skilled nursing services to medically fragile children and adults; nursing services in school settings in which its caregivers accompany patients to school; services to patients in its pediatric day healthcare centers; and employer of record support and personal care services, as well as in-clinic and home-based therapy services, such as physical, occupational, and speech services. The HHH segment provides home health services, including in-home skilled nursing services; physical, occupational, and speech therapy services; and medical social and aide services, as well as hospice services for patients and their families when a life-limiting illness no longer responds to cure-oriented treatments. The MS segment offers enteral nutrition supplies and other products, including formulas, supplies, and pumps to adults and children delivered on a periodic or as-needed basis. The company was incorporated in 2016 and is headquartered in Atlanta, Georgia.
Read More

Today's Range

Now: $8.33
Low: $8.28
High: $8.63

50 Day Range

MA: $8.85
Low: $8.08
High: $9.76

52 Week Range

Now: $8.33
Low: $3.67
High: $10.32

Volume

712,447 shs

Average Volume

1,277,359 shs

Market Capitalization

$1.74 billion

P/E Ratio

23.14

Dividend Yield

N/A

Beta

2.06

Frequently Asked Questions

What sell-side analysts currently cover shares of Aveanna Healthcare?

The following Wall Street sell-side analysts have issued research reports on Aveanna Healthcare in the last year: Barclays PLC, BMO Capital Markets, Jefferies Financial Group Inc., JPMorgan Chase & Co., Raymond James Financial, Inc., Royal Bank Of Canada, Truist Financial Corporation, UBS Group AG, Wall Street Zen, Weiss Ratings, William Blair, and Zacks Research.
View the latest analyst ratings for AVAH.

What is the current price target for Aveanna Healthcare?

0 Wall Street analysts have set twelve-month price targets for Aveanna Healthcare in the last year. Their average twelve-month price target is $11.06, suggesting a possible upside of 32.8%. Raymond James Financial, Inc. has the highest price target set, predicting AVAH will reach $13.00 in the next twelve months. UBS Group AG has the lowest price target set, forecasting a price of $10.00 for Aveanna Healthcare in the next year.
View the latest price targets for AVAH.

What is the current consensus analyst rating for Aveanna Healthcare?

Aveanna Healthcare currently has 5 hold ratings, 5 buy ratings and 1 strong buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Moderate Buy."
View the latest ratings for AVAH.

What other companies compete with Aveanna Healthcare?

Other companies that are similar to Aveanna Healthcare include Hims & Hers Health, Option Care Health, RadNet, PACS Group and Celcuity. Learn More about companies similar to Aveanna Healthcare.

How do I contact Aveanna Healthcare's investor relations team?

Aveanna Healthcare's physical mailing address is 400 INTERSTATE NORTH PARKWAY STE 1700, ATLANTA GA, 30339. The company's listed phone number is 770-441-1580 and its investor relations email address is [email protected]. The official website for Aveanna Healthcare is www.aveanna.com. Learn More about contacing Aveanna Healthcare investor relations.